Kennedy Capital Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Kennedy Capital Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-65,053	Closed	-$1.23M	–	755
2019 Q3	$1.23M	Buy	+65,053	New	+$744K	0.03%	582
2018 Q3	–	Sell	-196,652	Closed	-$3.11M	–	790
2018 Q2	$3.11M	Buy	+196,652	New	+$2.99M	0.06%	532

Kennedy Capital Management's ALDR Position: Q4 2019 in Review

Kennedy Capital Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 65,053 shares — an estimated $1.23M sold.

Kennedy Capital Management first reported a position in ALDR in Q2 2018 and held it in 2 quarters. The position peaked at $3.11M in Q2 2018. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Kennedy Capital Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Kennedy Capital Management sold 65,053 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.23M.
Kennedy Capital Management first reported a position in Alder Biopharmaceuticals in Q2 2018 and held it in 2 quarters.
Kennedy Capital Management's Alder Biopharmaceuticals position peaked at $3.11M in Q2 2018.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Kennedy Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.